Newspaper publication for financial results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Ltd has informed BSE that the newspaper advertisement of its un-audited standalone and consolidated financial results for the third quarter and nine months ended December 31, 2025 was published on February 15, 2026 in Financial Express (English) and Nava Telangana (Telugu). This is a routine SEBI compliance filing under Regulation 30. Key numbers from the consolidated results show Q3 FY26 total income of Rs 1,365.17 lakhs (up from Rs 1,222.10 lakhs in Q3 FY25) and net profit after tax of Rs 124.81 lakhs (up from Rs 82.00 lakhs, a ~52% rise). For the nine-month period, net profit dropped to Rs 345.38 lakhs from Rs 621.99 lakhs in the previous year, while total income was nearly flat at Rs 3,954.40 lakhs. Basic EPS for Q3 stood at Rs 0.56.
This is a regulatory disclosure of results already approved by the Board on February 13, 2026, so no new information for investors. The strong Q3 standalone profit growth (~52% YoY) is a positive signal, but the sharp decline in nine-month profits may draw attention and could weigh on short-term sentiment.